Immune Status After Being on Call for 24 Hrs
Impact of a 24-hour Shift Call on the Immune Status of Surgery Residents
University of Chicago
60 participants
Oct 17, 2024
OBSERVATIONAL
Conditions
Summary
Sleep deprivation is a prevalent problem in modern societies. Sleep deprivation can cause hormonal changes, such as an increase in cortisol, as well as inflammation. Animal studies have shown an increase in inflammatory cytokine production following sleep deprivation. Additionally, humans experiencing sleep deprivation may experience a decrease in natural killer cells and lymphocytes. Physicians, particularly those in surgical specialties, are often subjected to sleep deprivation as part of their medical residency training. This study hypothesizes that after 24-hour shifts, there is an increase in inflammatory response and impairment of the immune response against unspecific activation. This proposal aims to provide insight into the impact of sleep deprivation on the immune system of surgery residents by characterizing the phenotype and function of immune cells, as well as their correlation with biometric data.
Eligibility
Inclusion Criteria5
- Healthy subjects
- Surgery residents in a 24-hour shift rotation
- Gender of subjects: Males and females
- Age of subjects: 18 years old and older
- Racial and Ethnic Origin: Any race or ethnicity
Exclusion Criteria2
- Unwilling/unable to sign informed consent
- Vulnerable Subjects/Subject Capacity to provide consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
To characterize the phenotype and function of immune cells in surgery residents before and after a 24-hour shift, and before and after a month of being "on call". Along with to investigate the relationship between sleep deprivation, physical activity, and different immune responses.
Participants will be asked to wear their monitor every day for a week. The monitor will collect their step count, sleep and heart rate automatically. Participants will return their monitor at visit 5 (day 30) of the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06636318